摘要: Capecitabine is an oral prodrug of 5-fluorouracil used in the treatment adenocarcinoma colon. Neurotoxicity infrequently reported toxicity capecitabine. We report a case cerebellar ataxia secondary to capecitabine therapy.
elsevier.com
metapress.com参考文章(8)
Linda S.B. Couch, David L. Groteluschen, James A. Stewart, Daniel L. Mulkerin, Capecitabine-related neurotoxicity presenting as trismus. Clinical Colorectal Cancer. ,vol. 3, pp. 121- 123 ,(2003) , 10.3816/CCC.2003.N.019
B. Niemann, C. Rochlitz, R. Herrmann, M. Pless, Toxic encephalopathy induced by capecitabine Oncology. ,vol. 66, pp. 331- 335 ,(2004) , 10.1159/000078335
R B Diasio, T L Beavers, J T Carpenter, Familial deficiency of dihydropyrimidine dehydrogenase. Biochemical basis for familial pyrimidinemia and severe 5-fluorouracil-induced toxicity. Journal of Clinical Investigation. ,vol. 81, pp. 47- 51 ,(1988) , 10.1172/JCI113308
Johannes Sch�ller, Jim Cassidy, Etienne Dumont, Brigitte Roos, Ludger Banken, Kazushige Mori, Bruno Reigner, Masahiro Utoh, Erhard Weidekamm, Sarah Durston, Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients. Cancer Chemotherapy and Pharmacology. ,vol. 45, pp. 291- 297 ,(2000) , 10.1007/S002800050043
Noor A Pirzada, Imran I Ali, Rima M Dafer, Fluorouracil-induced neurotoxicity. Annals of Pharmacotherapy. ,vol. 34, pp. 35- 38 ,(2000) , 10.1345/APH.18425
A. Videnovic, I. Semenov, R. Chua-Adajar, L. Baddi, D. T. Blumenthal, A. C. Beck, T. Simuni, S. Futterer, W. Gradishar, C. Tellez, J. J. Raizer, Capecitabine-induced multifocal leukoencephalopathy: A report of five cases Neurology. ,vol. 65, pp. 1792- 1794 ,(2005) , 10.1212/01.WNL.0000187313.83515.7E
Lahiri, Boileau G, Piro Aj, Hall Tc, Cerebellar ataxia during 5-fluorouracil (NSC-19893) therapy. Cancer chemotherapy reports. ,vol. 55, pp. 595- ,(1971)
G Milano, M C Etienne, V Pierrefite, M Barberi-Heyob, R Deporte-Fety, N Renée, Dihydropyrimidine dehydrogenase deficiency and fluorouracil-related toxicity. British Journal of Cancer. ,vol. 79, pp. 627- 630 ,(1999) , 10.1038/SJ.BJC.6690098